Synmosa Biopharma (ROCO:4114) Institutional Ownership: 5.53% (As of Sep. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4114 Synmosa Biopharma Corp ROCO:4114
84 GF Score
Price NT$29.80
GF Value NT$33.98
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Synmosa Biopharma Institutional Ownership?

Synmosa Biopharma ROCO:4114 84 Institutional Ownership is 5.53% as of Sep. 02, 2026. GuruFocus rates ROCO:4114 with a GF Score™ of 84/100 and a GF Value™ of NT$33.98 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Synmosa Biopharma's institutional ownership is 5.53%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Synmosa Biopharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Synmosa Biopharma's Float Percentage Of Total Shares Outstanding is 0.00%.

Synmosa Biopharma Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Synmosa Biopharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synmosa Biopharma Institutional Ownership Chart

Synmosa Biopharma Historical Data

The historical data trend for Synmosa Biopharma can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-06-30 2026-07-31
Institutional Ownership 4.23 4.30 4.29 4.79 4.77 4.83 4.83 4.84 5.20 5.53
ROCO:4114
84GF Score
Synmosa Biopharma Corp ROCO:4114
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synmosa Biopharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 5.53% mean?
Synmosa Biopharma (ROCO:4114) has a Institutional Ownership of 5.53% as of Sep. 02, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Synmosa Biopharma and its competitors.
Is Synmosa Biopharma's Institutional Ownership too high?
Synmosa Biopharma's current Institutional Ownership is 5.53%. Overall, Synmosa Biopharma has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Synmosa Biopharma's Institutional Ownership compare to ZTS?
Synmosa Biopharma's Institutional Ownership of 5.53% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Synmosa Biopharma and its competitors. Synmosa Biopharma's current Institutional Ownership is 5.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synmosa Biopharma stock overvalued right now?
Based on GuruFocus' analysis, Synmosa Biopharma (ROCO:4114) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$33.98, compared to a current price of NT$29.80 — trading 12.3% below its estimated fair value. The current Institutional Ownership is 5.53%. Synmosa Biopharma's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Synmosa Biopharma (ROCO:4114), the current Institutional Ownership is 5.53% as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synmosa Biopharma (ROCO:4114) Overvalued in 2026?

Based on GuruFocus' analysis, Synmosa Biopharma stock appears to be undervalued. The current stock price of NT$29.80 is trading 12.3% below its estimated GF Value™ of NT$33.98. GuruFocus considers Synmosa Biopharma to be Modestly Undervalued.

Key valuation signals for ROCO:4114:

  • Institutional Ownership: 5.53%
  • GF Value™: NT$33.98 vs. price of NT$29.80 (12.3% below fair value)
  • GF Score™: 84/100 with 2 warning signs

No single metric tells the full story. See the ROCO:4114 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Synmosa Biopharma Business Description

Address No. 6, Gongye 1st Road, Hukou Township, Hsinchu County, Hsinchu, TWN
Synmosa Biopharma Corp is engaged in pharmaceuticals and medical devices, cosmetics, animal drugs, chemical food additives, beverages manufacturing and sales, and environmental drugs wholesale (retail), as well as the import and export of related businesses. Its segments include the Active Pharmaceutical Ingredients segment and the Generic Drugs segment. The Generic Drugs segment derives the majority of the revenue.
84GF Score

Get the complete analysis for ROCO:4114

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$29.80
Price
NT$33.98
GF Value